Table 1 HCC patients (n = 95) categorized by TSR and their clinical pathologic characteristics

Age, years

54.85 ± 9.05

50.16 ± 12.31

0.08

Serum albumin, g/L

43.01 ± 6.04

441.15 ± 5.36

0.25

Tumor size, cm

5.28 ± 3.00

8.96 ± 3.69

0.00

Platelet, 10^9/L

167.15 ± 79.14

173.97 ± 75.68

0.00

ALT, U/L

48.18 ± 21.25

42.46 ± 28.96

0.36

AST, U/L

54.52 ± 20.00

48.58 ± 39.57

0.47

PT, s

13.06 ± 1.39

13.38 ± 1.16

0.32

Gender

 Male

21

59

0.39

 Female

5

10

HBsAg

 Negative

2

12

0.23

 Positive

24

57

AFP, ng/mL

  ≤ 20

6

24

0.27

  > 20

20

45

CTP

 A

19

63

0.02

 B

7

6

Liver cirrhosis

 No

8

22

0.91

 Yes

18

47

Tumor encapsulation

 No

17

50

0.46

 Yes

9

19

Tumor number

 Single

13

58

0.00

 Multiple

13

11

Satellite nodules

 No

22

63

0.34

 Yes

4

6

Edmondson grade

 I–II

16

53

0.14

 III–IV

10

16

BCLC stage

 0

0

6

0.00

 A

12

51

 B

9

10

 C

5

2

TNM stage

 I

6

48

0.00

 II

11

10

 III

9

11